Structure

Physi-Chem Properties

Molecular Weight:  604.32
Volume:  623.102
LogP:  6.282
LogD:  4.291
LogS:  -3.856
# Rotatable Bonds:  18
TPSA:  166.14
# H-Bond Aceptor:  10
# H-Bond Donor:  6
# Rings:  3
# Heavy Atoms:  10

MedChem Properties

QED Drug-Likeness Score:  0.086
Synthetic Accessibility Score:  4.111
Fsp3:  0.606
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.714
MDCK Permeability:  2.5283532522735186e-05
Pgp-inhibitor:  0.447
Pgp-substrate:  0.968
Human Intestinal Absorption (HIA):  0.829
20% Bioavailability (F20%):  0.999
30% Bioavailability (F30%):  0.998

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.026
Plasma Protein Binding (PPB):  99.70677185058594%
Volume Distribution (VD):  0.598
Pgp-substrate:  0.8246524930000305%

ADMET: Metabolism

CYP1A2-inhibitor:  0.521
CYP1A2-substrate:  0.114
CYP2C19-inhibitor:  0.379
CYP2C19-substrate:  0.059
CYP2C9-inhibitor:  0.349
CYP2C9-substrate:  0.964
CYP2D6-inhibitor:  0.942
CYP2D6-substrate:  0.144
CYP3A4-inhibitor:  0.267
CYP3A4-substrate:  0.013

ADMET: Excretion

Clearance (CL):  6.225
Half-life (T1/2):  0.45

ADMET: Toxicity

hERG Blockers:  0.511
Human Hepatotoxicity (H-HT):  0.036
Drug-inuced Liver Injury (DILI):  0.036
AMES Toxicity:  0.232
Rat Oral Acute Toxicity:  0.017
Maximum Recommended Daily Dose:  0.724
Skin Sensitization:  0.966
Carcinogencity:  0.022
Eye Corrosion:  0.003
Eye Irritation:  0.377
Respiratory Toxicity:  0.06

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC7752

Natural Product ID:  NPC7752
Common Name*:   (3-Heptyl-5-Hydroxyphenyl) 2-Heptyl-4-Hydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-(Hydroxymethyl)Oxan-2-Yl]Oxybenzoate
IUPAC Name:   (3-heptyl-5-hydroxyphenyl) 2-heptyl-4-hydroxy-6-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate
Synonyms:  
Standard InCHIKey:  BOTABODRPOJDQC-FLHDZCCQSA-N
Standard InCHI:  InChI=1S/C33H48O10/c1-3-5-7-9-11-13-21-15-23(35)18-25(16-21)41-32(40)28-22(14-12-10-8-6-4-2)17-24(36)19-26(28)42-33-31(39)30(38)29(37)27(20-34)43-33/h15-19,27,29-31,33-39H,3-14,20H2,1-2H3/t27-,29+,30+,31-,33-/m1/s1
SMILES:  CCCCCCCc1cc(O)cc(c1)OC(=O)c1c(CCCCCCC)cc(cc1O[C@@H]1O[C@H](CO)[C@@H]([C@@H]([C@H]1O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL455232
PubChem CID:   24878794
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000238] Tannins
        • [CHEMONTID:0001710] Hydrolyzable tannins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33495 Acremonium sp. BCC 14080 Species n.a. Eukaryota n.a. n.a. n.a. PMID[18363379]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT91 Cell Line KB Homo sapiens IC50 > 25000.0 nM PMID[509009]
NPT639 Cell Line NCI-H187 Homo sapiens IC50 = 13900.0 nM PMID[509009]
NPT189 Cell Line Vero Chlorocebus aethiops IC50 = 43200.0 nM PMID[509009]
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 10000.0 nM PMID[509009]
NPT190 Organism Human herpesvirus 1 Human herpesvirus 1 IC50 = 7200.0 nM PMID[509009]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 4400.0 nM PMID[509009]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC7752 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9873 High Similarity NPC249977
0.9383 High Similarity NPC298778
0.9375 High Similarity NPC99216
0.9367 High Similarity NPC328093
0.9329 High Similarity NPC63105
0.9317 High Similarity NPC178851
0.9299 High Similarity NPC127406
0.9295 High Similarity NPC185103
0.9241 High Similarity NPC43638
0.9241 High Similarity NPC257309
0.9212 High Similarity NPC470454
0.9212 High Similarity NPC199533
0.9212 High Similarity NPC474345
0.9212 High Similarity NPC68381
0.9207 High Similarity NPC288152
0.9207 High Similarity NPC9002
0.9207 High Similarity NPC257011
0.9207 High Similarity NPC137871
0.9202 High Similarity NPC259905
0.9182 High Similarity NPC279732
0.9177 High Similarity NPC261866
0.9172 High Similarity NPC106625
0.9167 High Similarity NPC473631
0.9167 High Similarity NPC293227
0.9167 High Similarity NPC473717
0.9167 High Similarity NPC475662
0.9162 High Similarity NPC84494
0.9162 High Similarity NPC245059
0.9152 High Similarity NPC213052
0.9146 High Similarity NPC199079
0.9146 High Similarity NPC210808
0.9141 High Similarity NPC298847
0.913 High Similarity NPC300537
0.913 High Similarity NPC127782
0.9114 High Similarity NPC99233
0.9108 High Similarity NPC259182
0.9108 High Similarity NPC121001
0.9107 High Similarity NPC470452
0.9107 High Similarity NPC470453
0.9107 High Similarity NPC477860
0.9107 High Similarity NPC470448
0.9107 High Similarity NPC164047
0.9107 High Similarity NPC475161
0.9091 High Similarity NPC5029
0.9091 High Similarity NPC271385
0.9091 High Similarity NPC30432
0.9091 High Similarity NPC76128
0.9091 High Similarity NPC111536
0.9085 High Similarity NPC473202
0.9085 High Similarity NPC222455
0.908 High Similarity NPC70441
0.9068 High Similarity NPC101636
0.9062 High Similarity NPC73511
0.9062 High Similarity NPC308265
0.9062 High Similarity NPC43761
0.9059 High Similarity NPC473686
0.9059 High Similarity NPC221140
0.9059 High Similarity NPC475220
0.9059 High Similarity NPC229817
0.9059 High Similarity NPC475352
0.9057 High Similarity NPC206378
0.9051 High Similarity NPC299435
0.9051 High Similarity NPC260604
0.9045 High Similarity NPC70016
0.9045 High Similarity NPC215921
0.9045 High Similarity NPC190217
0.9042 High Similarity NPC46958
0.903 High Similarity NPC76047
0.9024 High Similarity NPC116745
0.9018 High Similarity NPC475979
0.9018 High Similarity NPC294722
0.9012 High Similarity NPC473043
0.9012 High Similarity NPC298171
0.9012 High Similarity NPC216752
0.9006 High Similarity NPC246469
0.9006 High Similarity NPC271270
0.9006 High Similarity NPC97285
0.9006 High Similarity NPC142860
0.9006 High Similarity NPC271479
0.9 High Similarity NPC161749
0.9 High Similarity NPC177742
0.9 High Similarity NPC6985
0.9 High Similarity NPC197896
0.9 High Similarity NPC23817
0.9 High Similarity NPC156457
0.9 High Similarity NPC258035
0.9 High Similarity NPC313163
0.8994 High Similarity NPC26195
0.8994 High Similarity NPC470604
0.8994 High Similarity NPC27408
0.8994 High Similarity NPC72649
0.8994 High Similarity NPC470605
0.8994 High Similarity NPC95090
0.8994 High Similarity NPC169248
0.8994 High Similarity NPC97052
0.8994 High Similarity NPC39351
0.8994 High Similarity NPC470603
0.8987 High Similarity NPC259767
0.8987 High Similarity NPC88484
0.8981 High Similarity NPC106025
0.8981 High Similarity NPC191154
0.8981 High Similarity NPC307780
0.8981 High Similarity NPC477240
0.8981 High Similarity NPC309979
0.8981 High Similarity NPC214454
0.8976 High Similarity NPC472386
0.8974 High Similarity NPC199335
0.897 High Similarity NPC43587
0.897 High Similarity NPC293629
0.8968 High Similarity NPC237208
0.8963 High Similarity NPC262222
0.8963 High Similarity NPC236934
0.8963 High Similarity NPC68592
0.8963 High Similarity NPC5778
0.8963 High Similarity NPC298666
0.8957 High Similarity NPC243930
0.8957 High Similarity NPC309025
0.8957 High Similarity NPC19709
0.8957 High Similarity NPC29830
0.8957 High Similarity NPC222936
0.8957 High Similarity NPC88023
0.8957 High Similarity NPC124155
0.8957 High Similarity NPC257566
0.8957 High Similarity NPC284960
0.8951 High Similarity NPC224530
0.8951 High Similarity NPC85707
0.8951 High Similarity NPC216496
0.8951 High Similarity NPC303913
0.8951 High Similarity NPC259957
0.8951 High Similarity NPC159579
0.8951 High Similarity NPC48093
0.8951 High Similarity NPC129217
0.8947 High Similarity NPC241847
0.8944 High Similarity NPC138811
0.8944 High Similarity NPC22062
0.8944 High Similarity NPC473634
0.8938 High Similarity NPC170475
0.8938 High Similarity NPC45165
0.8931 High Similarity NPC29763
0.8931 High Similarity NPC210003
0.8931 High Similarity NPC87304
0.8931 High Similarity NPC83283
0.8931 High Similarity NPC39360
0.8931 High Similarity NPC211158
0.8931 High Similarity NPC268950
0.8931 High Similarity NPC108706
0.8931 High Similarity NPC143851
0.8931 High Similarity NPC78021
0.8929 High Similarity NPC475233
0.8929 High Similarity NPC475246
0.8924 High Similarity NPC134819
0.8922 High Similarity NPC175230
0.8922 High Similarity NPC472054
0.8922 High Similarity NPC25724
0.8922 High Similarity NPC263119
0.8922 High Similarity NPC46640
0.8922 High Similarity NPC34436
0.8922 High Similarity NPC98776
0.8922 High Similarity NPC166674
0.8922 High Similarity NPC172033
0.8922 High Similarity NPC88560
0.8922 High Similarity NPC219600
0.8917 High Similarity NPC270160
0.8917 High Similarity NPC237440
0.8917 High Similarity NPC476684
0.8916 High Similarity NPC44328
0.8916 High Similarity NPC244776
0.8916 High Similarity NPC177731
0.8916 High Similarity NPC105095
0.8916 High Similarity NPC116864
0.8916 High Similarity NPC79056
0.891 High Similarity NPC302989
0.891 High Similarity NPC23084
0.8909 High Similarity NPC477502
0.8909 High Similarity NPC229729
0.8903 High Similarity NPC29577
0.8903 High Similarity NPC134621
0.8902 High Similarity NPC22832
0.8902 High Similarity NPC165720
0.8902 High Similarity NPC311830
0.8896 High Similarity NPC475382
0.8896 High Similarity NPC131745
0.8896 High Similarity NPC189142
0.8896 High Similarity NPC27942
0.8896 High Similarity NPC259834
0.8896 High Similarity NPC472876
0.8896 High Similarity NPC22324
0.8896 High Similarity NPC44947
0.8896 High Similarity NPC190450
0.8896 High Similarity NPC77660
0.8895 High Similarity NPC65489
0.8889 High Similarity NPC231254
0.8889 High Similarity NPC472320
0.8889 High Similarity NPC473623
0.8889 High Similarity NPC470358
0.8889 High Similarity NPC110349
0.8889 High Similarity NPC153342
0.8882 High Similarity NPC65003
0.8882 High Similarity NPC129827
0.8882 High Similarity NPC60966

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC7752 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9 High Similarity NPD4381 Clinical (unspecified phase)
0.8916 High Similarity NPD7074 Phase 3
0.8855 High Similarity NPD7804 Clinical (unspecified phase)
0.8855 High Similarity NPD7054 Approved
0.8812 High Similarity NPD7819 Suspended
0.8802 High Similarity NPD7472 Approved
0.8757 High Similarity NPD7808 Phase 3
0.8698 High Similarity NPD7251 Discontinued
0.8683 High Similarity NPD3818 Discontinued
0.865 High Similarity NPD7075 Discontinued
0.8647 High Similarity NPD4338 Clinical (unspecified phase)
0.8639 High Similarity NPD6797 Phase 2
0.8588 High Similarity NPD6559 Discontinued
0.8519 High Similarity NPD1934 Approved
0.8476 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.8466 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8395 Intermediate Similarity NPD4380 Phase 2
0.8382 Intermediate Similarity NPD8312 Approved
0.8382 Intermediate Similarity NPD8313 Approved
0.8343 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8343 Intermediate Similarity NPD6166 Phase 2
0.8304 Intermediate Similarity NPD5844 Phase 1
0.8303 Intermediate Similarity NPD3817 Phase 2
0.8303 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8293 Intermediate Similarity NPD6801 Discontinued
0.828 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8274 Intermediate Similarity NPD6959 Discontinued
0.8242 Intermediate Similarity NPD1465 Phase 2
0.8225 Intermediate Similarity NPD6232 Discontinued
0.8217 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8217 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.8187 Intermediate Similarity NPD7473 Discontinued
0.8166 Intermediate Similarity NPD7199 Phase 2
0.8165 Intermediate Similarity NPD1549 Phase 2
0.814 Intermediate Similarity NPD7228 Approved
0.8137 Intermediate Similarity NPD6799 Approved
0.8133 Intermediate Similarity NPD2801 Approved
0.8121 Intermediate Similarity NPD7411 Suspended
0.8103 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.8095 Intermediate Similarity NPD7783 Phase 2
0.8086 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8086 Intermediate Similarity NPD2532 Approved
0.8086 Intermediate Similarity NPD2533 Approved
0.8086 Intermediate Similarity NPD2534 Approved
0.8085 Intermediate Similarity NPD8151 Discontinued
0.8084 Intermediate Similarity NPD5402 Approved
0.8072 Intermediate Similarity NPD37 Approved
0.8061 Intermediate Similarity NPD6599 Discontinued
0.8047 Intermediate Similarity NPD6234 Discontinued
0.8036 Intermediate Similarity NPD4965 Approved
0.8036 Intermediate Similarity NPD4966 Approved
0.8036 Intermediate Similarity NPD4967 Phase 2
0.8036 Intermediate Similarity NPD7768 Phase 2
0.8025 Intermediate Similarity NPD1511 Approved
0.8024 Intermediate Similarity NPD8455 Phase 2
0.8023 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD3749 Approved
0.7988 Intermediate Similarity NPD5403 Approved
0.7965 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.795 Intermediate Similarity NPD3750 Approved
0.795 Intermediate Similarity NPD4628 Phase 3
0.7944 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7939 Intermediate Similarity NPD1653 Approved
0.7929 Intermediate Similarity NPD3882 Suspended
0.7927 Intermediate Similarity NPD1512 Approved
0.7925 Intermediate Similarity NPD2796 Approved
0.7914 Intermediate Similarity NPD7435 Discontinued
0.7866 Intermediate Similarity NPD5401 Approved
0.7862 Intermediate Similarity NPD1510 Phase 2
0.7853 Intermediate Similarity NPD7685 Pre-registration
0.7829 Intermediate Similarity NPD3751 Discontinued
0.7821 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7803 Intermediate Similarity NPD3787 Discontinued
0.7791 Intermediate Similarity NPD5494 Approved
0.7784 Intermediate Similarity NPD3226 Approved
0.7771 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.776 Intermediate Similarity NPD7874 Approved
0.776 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7758 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7754 Intermediate Similarity NPD6776 Approved
0.7754 Intermediate Similarity NPD6779 Approved
0.7754 Intermediate Similarity NPD6778 Approved
0.7754 Intermediate Similarity NPD6780 Approved
0.7754 Intermediate Similarity NPD6781 Approved
0.7754 Intermediate Similarity NPD6782 Approved
0.7754 Intermediate Similarity NPD6777 Approved
0.7753 Intermediate Similarity NPD7240 Approved
0.773 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7725 Intermediate Similarity NPD7697 Approved
0.7725 Intermediate Similarity NPD7696 Phase 3
0.7725 Intermediate Similarity NPD7698 Approved
0.7722 Intermediate Similarity NPD1240 Approved
0.7702 Intermediate Similarity NPD1551 Phase 2
0.7702 Intermediate Similarity NPD2935 Discontinued
0.7684 Intermediate Similarity NPD7870 Phase 2
0.7684 Intermediate Similarity NPD7871 Phase 2
0.768 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7656 Intermediate Similarity NPD7701 Phase 2
0.764 Intermediate Similarity NPD3748 Approved
0.7625 Intermediate Similarity NPD1607 Approved
0.7622 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7604 Intermediate Similarity NPD7584 Approved
0.7602 Intermediate Similarity NPD7930 Approved
0.76 Intermediate Similarity NPD5710 Approved
0.76 Intermediate Similarity NPD5711 Approved
0.7593 Intermediate Similarity NPD6099 Approved
0.7593 Intermediate Similarity NPD6100 Approved
0.7592 Intermediate Similarity NPD8319 Approved
0.7592 Intermediate Similarity NPD8320 Phase 1
0.759 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.758 Intermediate Similarity NPD6832 Phase 2
0.7579 Intermediate Similarity NPD6823 Phase 2
0.7565 Intermediate Similarity NPD7585 Approved
0.7561 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7553 Intermediate Similarity NPD7700 Phase 2
0.7553 Intermediate Similarity NPD7699 Phase 2
0.7546 Intermediate Similarity NPD7266 Discontinued
0.7546 Intermediate Similarity NPD2346 Discontinued
0.7545 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD8434 Phase 2
0.7541 Intermediate Similarity NPD8150 Discontinued
0.7538 Intermediate Similarity NPD7801 Approved
0.7513 Intermediate Similarity NPD7583 Approved
0.75 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD1613 Approved
0.7487 Intermediate Similarity NPD6534 Approved
0.7487 Intermediate Similarity NPD6535 Approved
0.7471 Intermediate Similarity NPD7458 Discontinued
0.7471 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7456 Intermediate Similarity NPD920 Approved
0.7455 Intermediate Similarity NPD1243 Approved
0.7455 Intermediate Similarity NPD2800 Approved
0.7453 Intermediate Similarity NPD1933 Approved
0.7453 Intermediate Similarity NPD230 Phase 1
0.7429 Intermediate Similarity NPD919 Approved
0.7423 Intermediate Similarity NPD7033 Discontinued
0.7403 Intermediate Similarity NPD5953 Discontinued
0.7401 Intermediate Similarity NPD7229 Phase 3
0.7389 Intermediate Similarity NPD7286 Phase 2
0.7389 Intermediate Similarity NPD1203 Approved
0.7381 Intermediate Similarity NPD7390 Discontinued
0.7376 Intermediate Similarity NPD8155 Clinical (unspecified phase)
0.7349 Intermediate Similarity NPD6674 Discontinued
0.7349 Intermediate Similarity NPD1652 Phase 2
0.7346 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD6355 Discontinued
0.7346 Intermediate Similarity NPD447 Suspended
0.7337 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.733 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7321 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7317 Intermediate Similarity NPD2799 Discontinued
0.7317 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD6651 Approved
0.7296 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD6273 Approved
0.7292 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7284 Intermediate Similarity NPD4060 Phase 1
0.7283 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD2797 Approved
0.7268 Intermediate Similarity NPD7680 Approved
0.7267 Intermediate Similarity NPD3268 Approved
0.7267 Intermediate Similarity NPD6798 Discontinued
0.7263 Intermediate Similarity NPD3926 Phase 2
0.7262 Intermediate Similarity NPD6190 Approved
0.725 Intermediate Similarity NPD4908 Phase 1
0.725 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7249 Intermediate Similarity NPD6214 Clinical (unspecified phase)
0.7249 Intermediate Similarity NPD6213 Phase 3
0.7249 Intermediate Similarity NPD6212 Phase 3
0.7247 Intermediate Similarity NPD8127 Discontinued
0.7244 Intermediate Similarity NPD1091 Approved
0.7239 Intermediate Similarity NPD5124 Phase 1
0.7239 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7228 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD3027 Phase 3
0.7197 Intermediate Similarity NPD1608 Approved
0.7197 Intermediate Similarity NPD9717 Approved
0.7194 Intermediate Similarity NPD7999 Approved
0.7178 Intermediate Similarity NPD943 Approved
0.716 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.716 Intermediate Similarity NPD2313 Discontinued
0.7159 Intermediate Similarity NPD4288 Approved
0.7151 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD1610 Phase 2
0.7134 Intermediate Similarity NPD422 Phase 1
0.7128 Intermediate Similarity NPD5006 Approved
0.7128 Intermediate Similarity NPD5005 Approved
0.7127 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD2344 Approved
0.7125 Intermediate Similarity NPD2798 Approved
0.712 Intermediate Similarity NPD4363 Phase 3
0.712 Intermediate Similarity NPD4360 Phase 2
0.7117 Intermediate Similarity NPD6233 Phase 2
0.7108 Intermediate Similarity NPD4308 Phase 3
0.7099 Intermediate Similarity NPD4625 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data